Invasive candidiasis is a dread complication in hospitalized patients, char
acterized by a mortality comparable to that of septic shock (40% to 60%). I
ts incidence in hospitalized patients is 0.5/1000 admissions, but it compli
cates about 10 per 1,000 admissions in critical care where it represents 10
% to 15% of all nosocomial infections. Although a high proportion of hospit
alized patients may become colonized with Candida spp, the clinical signs o
f infection manifest only late, rending it difficult to diagnose. A better
knowledge of their pathophysiology and the availability of triazoles compou
nds, less toxic than amphotericin B, allowed the concept of early empirical
or preemptive treatment. These strategies are based on the prompt identifi
cation of risk factors and require continuous attention from skilled physic
ians. However, the prescription of triazoles has to be restricted to carefu
lly selected groups of patients to avoid the emergence and the disseminatio
n of resistant strains. (C) 2001 Editions scientifiques et medicales Elsevi
er SAS.